Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesPharmacotherapy for the Obese Patient
Primary Care: Clinics in Office Practice, 06/15/09
Dickerson LM et al. - The long-term safety of many antiobesity pharmacologic regimens has not been adequately evaluated. If recommended and prescribed, pharmacologic agents should be an adjunct to a structured diet and exercise regimen. Unfortunately, weight gain after discontinuation of antiobesity agents is common. In addition, the effect of weight loss obtained through the use of pharmacotherapeutic agents on overall morbidity and mortality has not been established.
Related Articles
Obesity, intentional weight loss and physical disability in older adults
Obesity Reviews, 11/18/09
Relevance Score: 94%
Early life influences on obesity risk: maternal overnutrition and programming of obesity
Expert Review of Endocrinology & Metabolism, 11/12/09
Relevance Score: 94%
Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
Amylin Pharmaceuticals, 10/20/09
Relevance Score: 94%
Obesity as a disease state: A new paradigm for diagnosis and treatment
Clinical Cornerstone, 10/21/09
Relevance Score: 93%
Obesity as a Social Problem in the United States
Policy, Politics, & Nursing Practice, 10/01/09
Relevance Score: 93%
Today in Obesity...keeping you current
Receive free subspecialty "5-minute updates" via email
New central targets for the treatment of obesity
British Journal of Clinical Pharmacology, 12/11/09
Obesity in older adults: relationship to functional limitation
Current Opinion in Clinical Nutrition & Metabolic Care, 12/11/09
Obesity hypertension: the emerging role of leptin in renal and cardiovascular dyshomeostasis
Current Opinion in Nephrology and Hypertension, 12/11/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment with alpha-lipoic acid reduces asymmetric dimethylarginine in patients with type 2 diabetes mellitus
Translational Research, The Journal of Laboratory and Clinical Medicine, 12/11/09
Insulin therapy in type 2 diabetes: insulin analogue mix 50, a potential role in reducing postprandial hyperglycaemia and cardiovascular disease
Expert Opinion in Pharmacotherapy, 12/11/09
Effect of Raloxifene on Serum Lipids for Type 2 Diabetic Menopausal Women with or without Statin Treatment
Medical Principles and Practice, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor